142 related articles for article (PubMed ID: 8078010)
1. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children.
La Quaglia MP; Caldwell C; Lucas A; Corbally M; Heller G; Steinherz L; Brown AE; Groeger J; Exelby PR
J Pediatr Surg; 1994 Jun; 29(6):742-5. PubMed ID: 8078010
[TBL] [Abstract][Full Text] [Related]
2. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients.
Jones GR; Konsler GK; Dunaway RP; Lacey SR; Azizkhan RG
J Pediatr Surg; 1993 Mar; 28(3):350-5; discussion 355-7. PubMed ID: 8468645
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis.
Atkinson JB; Chamberlin K; Boody BA
J Pediatr Surg; 1998 May; 33(5):714-6. PubMed ID: 9607475
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
Bagnall HA; Gomperts E; Atkinson JB
Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
[TBL] [Abstract][Full Text] [Related]
5. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
[TBL] [Abstract][Full Text] [Related]
6. Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase.
Haire WD; Lieberman RP
JPEN J Parenter Enteral Nutr; 1992; 16(2):129-32. PubMed ID: 1556806
[TBL] [Abstract][Full Text] [Related]
7. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters (PASSPORT 1).
Kumwenda MJ; Mitra S; Khawaja A; Inston N; Nightingale P
J Vasc Access; 2019 Nov; 20(6):752-759. PubMed ID: 31466489
[TBL] [Abstract][Full Text] [Related]
8. Urokinase therapy for Silastic catheter-induced intravascular thrombi in infants and children.
Curnow A; Idowu J; Behrens E; Toomey F; Georgeson K
Arch Surg; 1985 Nov; 120(11):1237-40. PubMed ID: 4051728
[TBL] [Abstract][Full Text] [Related]
9. Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
Bonkain F; Stolear JC; Catalano C; Vandervelde D; Treille S; Couttenye MM; Dhondt A; Libertalis M; Allamani M; Madhoun P; Van Craenenbroeck AH; Vanommeslaeghe F; Van Hulle F; Durieux P; Van Limberghen I; Tielemans C; Wissing KM
PLoS One; 2021; 16(5):e0251793. PubMed ID: 34015014
[TBL] [Abstract][Full Text] [Related]
10. Early detection and simplified management of obstructed Hickman and Broviac catheters.
Stokes DC; Rao BN; Mirro J; Mackert PW; Austin B; Colten M; Hancock ML
J Pediatr Surg; 1989 Mar; 24(3):257-62. PubMed ID: 2709289
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
[TBL] [Abstract][Full Text] [Related]
12. Prevention of indwelling central venous catheter sepsis.
Daghistani D; Horn M; Rodriguez Z; Schoenike S; Toledano S
Med Pediatr Oncol; 1996 Jun; 26(6):405-8. PubMed ID: 8614377
[TBL] [Abstract][Full Text] [Related]
13. Infection rates of Broviac-Hickman catheters and implantable venous devices.
Wurzel CL; Halom K; Feldman JG; Rubin LG
Am J Dis Child; 1988 May; 142(5):536-40. PubMed ID: 3358396
[TBL] [Abstract][Full Text] [Related]
14. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters.
Twardowski ZJ
Am J Kidney Dis; 1998 May; 31(5):841-7. PubMed ID: 9590195
[TBL] [Abstract][Full Text] [Related]
15. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
van Rooden CJ; Schippers EF; Guiot HF; Barge RM; Hovens MM; van der Meer FJ; Rosendaal FR; Huisman MV
J Clin Oncol; 2008 Jan; 26(3):428-33. PubMed ID: 18202420
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients.
De Sio L; Jenkner A; Milano GM; Ilari I; Fidani P; Castellano A; Gareri R; Donfrancesco A
Pediatr Infect Dis J; 2004 Oct; 23(10):963-5. PubMed ID: 15602201
[TBL] [Abstract][Full Text] [Related]
17. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
[TBL] [Abstract][Full Text] [Related]
18. A randomized, prospective trial of standard Hickman compared with Groshong central venous catheters in pediatric oncology patients.
Warner BW; Haygood MM; Davies SL; Hennies GA
J Am Coll Surg; 1996 Aug; 183(2):140-4. PubMed ID: 8696545
[TBL] [Abstract][Full Text] [Related]
19. Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients.
Horne MK; Mayo DJ
J Clin Oncol; 1997 Jul; 15(7):2709-14. PubMed ID: 9215844
[TBL] [Abstract][Full Text] [Related]
20. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters in haematology and oncology patients (PASSPORT 2).
Kumwenda MJ; Dougherty L; Jackson A; Hill S
J Vasc Access; 2021 Jul; 22(4):568-574. PubMed ID: 32867568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
